Cargando…

Mitochondrial Migraine: Disentangling the angiopathy paradigm in m.3243A>G patients

Migraine, characterized by recurrent attacks of predominantly unilateral throbbing headache, affects approximately 15% of the adult population and is an important cause of disability worldwide. Knowledge required for the development of new classes of antimigraine drugs might come from studying rare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smeitink, Jan, Koene, Saskia, Beyrath, Julien, Saris, Christiaan, Turnbull, Douglas, Janssen, Mirian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498836/ https://www.ncbi.nlm.nih.gov/pubmed/31240155 http://dx.doi.org/10.1002/jmd2.12017

Ejemplares similares

The KHENERGY Study: Safety and Efficacy of KH176 in Mitochondrial m.3243A>G Spectrum Disorders
por: Janssen, Mirian C.H., et al.
Publicado: (2018)

Quantification of gait in mitochondrial m.3243A > G patients: a validation study
por: Ramakers, Rob, et al.
Publicado: (2017)

Erratum to: Quantification of gait in mitochondrial m.3243A > G patients: a validation study
por: Ramakers, Rob, et al.
Publicado: (2017)

Fear of disease progression in carriers of the m.3243A > G mutation
por: Custers, José A. E., et al.
Publicado: (2018)

Quality of life, fatigue and mental health in patients with the m.3243A > G mutation and its correlates with genetic characteristics and disease manifestation
por: Verhaak, Christianne, et al.
Publicado: (2016)

Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation
por: de Laat, Paul, et al.
Publicado: (2012)

Erratum to: Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A>G mutation
por: de Laat, Paul, et al.
Publicado: (2012)

Identifying trajectories of fatigue in patients with primary mitochondrial disease due to the m.3243A > G variant
por: Klein, Inge‐Lot, et al.
Publicado: (2022)

Three families with ‘de novo’ m.3243A > G mutation
por: de Laat, Paul, et al.
Publicado: (2016)

Intra‐patient variability of heteroplasmy levels in urinary epithelial cells in carriers of the m.3243A>G mutation
por: de Laat, Paul, et al.
Publicado: (2018)

Mitochondrial disorders in children: toward development of small‐molecule treatment strategies
por: Koopman, Werner JH, et al.
Publicado: (2016)

Optimal Estimate for Energy Requirements in Adult Patients With the m.3243A>G Mutation in Mitochondrial DNA
por: Zweers, Heidi E. E., et al.
Publicado: (2020)

KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers
por: Koene, Saskia, et al.
Publicado: (2017)

Five non-mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes phenotype adult patients with m.3243A>G mutation after kidney transplantation: follow-up and review of the literature
por: de Laat, Paul, et al.
Publicado: (2019)

Mitochondrial medicine
por: Koene, Saskia, et al.
Publicado: (2011)

Is 2D speckle tracking echocardiography useful for detecting and monitoring myocardial dysfunction in adult m.3243A>G carriers? — a retrospective pilot study
por: Koene, S., et al.
Publicado: (2017)

Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons
por: Klein Gunnewiek, Teun M., et al.
Publicado: (2021)

Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction
por: Koene, Saskia, et al.
Publicado: (2010)

Response to Energy Requirements in m.3243A>G Carriers Depend on Multiple Factors
por: Zweers, Heidi E. E., et al.
Publicado: (2020)

Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors
por: Pickett, Sarah J., et al.
Publicado: (2018)

Arrhythmia prevalence and sudden death risk in adults with the m.3243A>G mitochondrial disorder
por: Bourke, John P, et al.
Publicado: (2022)

Small-fiber neuropathy and the 3243A>G mutation in mitochondrial DNA
por: Henning, F., et al.
Publicado: (2007)

Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G
por: Majamaa-Voltti, Kirsi, et al.
Publicado: (2002)

Mitochondrial m.3243A > G mutation and carotid artery dissection
por: Mancuso, Michelangelo, et al.
Publicado: (2016)

Cardiomyopathy is common in patients with the mitochondrial DNA m.3243A>G mutation and correlates with mutation load
por: Hollingsworth, Kieren G., et al.
Publicado: (2012)

Postlingual Hearing Loss as a Mitochondrial 3243A>G Mutation Phenotype
por: Iwanicka-Pronicka, Katarzyna, et al.
Publicado: (2012)

Pathogenic mitochondrial DNA 3243A>G mutation: From genetics to phenotype
por: Li, Danyang, et al.
Publicado: (2022)

Neuropathological hallmarks in autopsied cases with mitochondrial diseases caused by the mitochondrial 3243A>G mutation
por: Miyahara, Hiroaki, et al.
Publicado: (2023)

Psychological functioning in children suspected for mitochondrial disease: the need for care
por: van de Loo, Kim F. E., et al.
Publicado: (2020)

Mitochondrial vasculopathy due to the m.3243A > G mutation is not restricted to the carotid artery
por: Finsterer, Josef, et al.
Publicado: (2016)

Phenotypic Heterogeneity in 5 Family Members with the Mitochondrial Variant m.3243A>G
por: Finsterer, Josef, et al.
Publicado: (2020)

The Mitochondrial m.3243A>G Mutation on the Dish, Lessons from In Vitro Models
por: Ryytty, Sanna, et al.
Publicado: (2023)

Mitochondrial A3243G mutation causes mitochondrial encephalomyopathy in a Chinese patient: Case report
por: Liu, Xiao-Qun, et al.
Publicado: (2019)

Impact of Mitochondrial A3243G Heteroplasmy on Mitochondrial Bioenergetics and Dynamics of Directly Reprogrammed MELAS Neurons
por: Lin, Dar-Shong, et al.
Publicado: (2022)

Discrete gait characteristics are associated with m.3243A>G and m.8344A>G variants of mitochondrial disease and its pathological consequences
por: Galna, Brook, et al.
Publicado: (2013)

Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease()()()
por: Bates, Matthew G.D., et al.
Publicado: (2013)

Feeding difficulties, a key feature of the Drosophila NDUFS4 mitochondrial disease model
por: Foriel, Sarah, et al.
Publicado: (2018)

mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
por: Grady, John P, et al.
Publicado: (2018)

Sonlicromanol’s active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth
por: Jiang, Xiaolan, et al.
Publicado: (2021)

Cognitive deficits in adult m.3243A>G‐ and m.8344A>G‐related mitochondrial disease: importance of correcting for baseline intellectual ability
por: Moore, Heather L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1piqa28t01cckid40dg89h42u9